DEXCOM, INC. Unrecognized Tax Benefits that Would Impact Effective Tax Rate
DEXCOM, INC. (DXCM) had Unrecognized Tax Benefits that Would Impact Effective Tax Rate of $40.80 million as of 2025-12-31, per its 10-K filed 2026-02-12.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate · last filed 2026-02-12
- 2025-12-31: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $40.80M.
- 2024-12-31: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $40.70M.
- 2023-12-31: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $37.00M.
- 2022-12-31: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $32.50M.
| Period end | Unrecognized Tax Benefits that Would Impact Effective Tax Rate |
|---|---|
| 2025-12-31 | $40.80M 10-K · filed 2026-02-12 |
| 2024-12-31 | $40.70M 10-K · filed 2026-02-12 |
| 2023-12-31 | $37.00M 10-K · filed 2026-02-12 |
| 2022-12-31 | $32.50M 10-K · filed 2025-02-18 |
| 2021-12-31 | $29.50M 10-K · filed 2024-02-08 |
| 2020-12-31 | $23.50M 10-K · filed 2023-02-09 |
| 2019-12-31 | $0.00 10-K · filed 2022-02-14 |
| 2018-12-31 | $0.00 10-K · filed 2021-02-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |